Lawmakers press Trump to reconsider rule limiting imported meds from Canada and abroad

A bipartisan group of lawmakers is urging the Trump administration to reverse a pending rule that would restrict Americans from buying medicines from licensed international pharmacies, primarily in Canada. The rule, if enacted, would limit access to lower-cost drugs, a key issue for U.S. patients. The outcome is uncertain, but the push highlights ongoing tension between drug pricing concerns and regulatory control.